Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerBilling CodesEndocrine, Nutritional and Metabolic Diseases and DisordersDRG 643-endocrine-disorders-with-mcc
    Ask Trek AI about this page

    Endocrine Disorders with MCC: Inpatient Reimbursement Overview

    DRG 643 addresses inpatient admissions for endocrine, nutritional, and metabolic disorders with a Major Complication or Comorbidity, capturing cases with higher clinical severity. Correct assignment impacts Medicare inpatient reimbursement because the Diagnosis-Related Group reflects greater resource needs and yields higher payment relative to less complex endocrine groups.

    Customize your policy alerts

    Sign up for drg 643 policy alerts

    Get alerted when payer policies referencing 643 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    DRG 643 Overview

    DRG 643 covers inpatient admissions for primary endocrine, nutritional, and metabolic disorders accompanied by a Major Complication or Comorbidity. Typical clinical presentations include severe endocrine crises, complicated diabetes with systemic effects, or significant metabolic derangements requiring intensive inpatient management. This Diagnosis-Related Group matters for Medicare payment because cases assigned here generally reflect higher resource use and trigger higher inpatient reimbursement relative to less complex endocrine Diagnosis-Related Groups. Accurate coding of diagnoses and documented severity directly influences assignment to this Diagnosis-Related Group and associated payment levels.

    Table of contents

    Progress1 / 3

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical Trials

    • Acute biochemical stabilization studies: Trials focused on rapid inpatient management strategies for severe endocrine crises (for example, acute adrenal insufficiency, myxedema coma, or thyroid storm) evaluate protocols for hormonal replacement timing, dosing adjustments, and supportive care measures in critically ill hospitalized adults. These studies enroll patients admitted with life-threatening endocrine decompensation and measure short-term endpoints such as time to hemodynamic stabilization, normalization of metabolic parameters, and in-hospital complication rates. Results inform hospital protocols and resource utilization decisions for clinicians and payers by identifying approaches that reduce ICU length of stay and avoid readmissions.
    • Comparative effectiveness research on comorbidity-driven treatment pathways: Pragmatic trials or observational comparative studies assess different inpatient and transitional-care strategies for patients with endocrine diseases complicated by major comorbidities (for example diabetes with severe infection, endocrine malignancy with organ dysfunction, or chronic adrenal insufficiency with cardiovascular disease). These studies compare care bundles—such as inpatient glycemic management algorithms, steroid-sparing approaches, or integrated endocrinology–hospitalist models—across heterogeneous patient subgroups to determine which approaches yield better short-term outcomes, fewer complications, and lower total costs of care. Findings help payers and hospital administrators allocate resources and design reimbursement incentives that prioritize effective pathways for high-risk, high-cost patients within this DRG.
    • Post-discharge outcomes and transitional-care interventions: Prospective cohort studies and interventional trials examine discharge planning, outpatient follow-up timing, medication reconciliation, and patient education programs for patients hospitalized with serious endocrine disorders who have major comorbidities. These studies target readmission rates, adherence to endocrine replacement or adjustment regimens, quality-of-life measures, and emergency department utilization within 30–90 days after discharge among older adults and multi-morbid patients. Evidence from this research guides care managers and payers in investment decisions for transitional-care services that can reduce avoidable readmissions and downstream costs associated with complications common in this DRG.

    Related Codes

    614-ADRENAL-AND-PITUITARY-PROCEDURES-WITH-CC-MCC

    Adrenal and Pituitary Procedures with CC/MCC: Inpatient Reimbursement Overview

    615-ADRENAL-AND-PITUITARY-PROCEDURES-WITHOUT-CC-MCC

    Adrenal and Pituitary Procedures without CC/MCC: Inpatient Reimbursement Overview

    616-AMPUTATION-OF-LOWER-LIMB-FOR-ENDOCRINE-NUTRITIONAL-AND-METABOLIC-DISORDERS-WITH-MCC

    Amputation of Lower Limb for Endocrine, Nutritional and Metabolic Disorders with MCC: Inpatient Reimbursement Overview

    617-AMPUTATION-OF-LOWER-LIMB-FOR-ENDOCRINE-NUTRITIONAL-AND-METABOLIC-DISORDERS-WITH-CC

    Amputation of Lower Limb for Endocrine, Nutritional and Metabolic Disorders with CC: Inpatient Reimbursement Overview

    618-AMPUTATION-OF-LOWER-LIMB-FOR-ENDOCRINE-NUTRITIONAL-AND-METABOLIC-DISORDERS-WITHOUT-CC-MCC

    Amputation of Lower Limb for Endocrine, Nutritional and Metabolic Disorders without CC/MCC: Inpatient Reimbursement Overview

    619-O-R-PROCEDURES-FOR-OBESITY-WITH-MCC

    O.R. Procedures for Obesity with MCC: Inpatient Reimbursement Overview

    620-O-R-PROCEDURES-FOR-OBESITY-WITH-CC

    O.R. Procedures for Obesity with CC: Inpatient Reimbursement Overview

    621-O-R-PROCEDURES-FOR-OBESITY-WITHOUT-CC-MCC

    O.R. Procedures for Obesity without CC/MCC: Inpatient Reimbursement Overview

    622-SKIN-GRAFTS-AND-WOUND-DEBRIDEMENT-FOR-ENDOCRINE-NUTRITIONAL-AND-METABOLIC-DISORDERS-WITH-MCC

    Skin Grafts and Wound Debridement for Endocrine, Nutritional and Metabolic Disorders with MCC: Inpatient Reimbursement Overview

    623-SKIN-GRAFTS-AND-WOUND-DEBRIDEMENT-FOR-ENDOCRINE-NUTRITIONAL-AND-METABOLIC-DISORDERS-WITH-CC

    Skin Grafts and Wound Debridement for Endocrine, Nutritional and Metabolic Disorders with CC: Inpatient Reimbursement Overview

    Showing 1–10 of 25

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.